BJ McMahon, P Holck, L Bulkow, M Snowball - Annals of internal medicine, 2001 - Am Coll Physicians Objective: To determine the incidence of and risk factors for adverse events
(hepatocellular carcinoma and end-stage liver disease) and clearance of
hepatitis B e antigen (HBeAg) and surface antigen (HBsAg) in carriers of HBV. Cited by 201 - Related articles - All 9 versions
YS Hsu, RN Chien, CT Yeh, IS Sheen, HY … - Hepatology, 2002 - interscience.wiley.com During the course of chronic hepatitis B virus (HBV) infection, hepatitis B e
antigen (HBeAg) seroconversion to its antibody (anti-HBe) often coincides with
normalization of liver biochemical test and clinical remission, but data ... Cited by 292 - Related articles - BL Direct - All 4 versions
Y Liaw, IS Sheen, TJ Chen, CM Chu, CC Pao - Hepatology, 1991 - interscience.wiley.com To investigate the incidence, determinants and significance of delayed clearance
of serum HBsAg in chronic hepatitis B virus infection, a prospective follow-up
study was conducted in two consecutive groups of patients. Group I ... Cited by 152 - Related articles - All 3 versions
AS Lok, CL Lai, PC Wu, EK Leung, TS Lam - Gastroenterology, 1987 - ncbi.nlm.nih.gov Five hundred twelve (373 men, 139 women) patients, aged 1-75 yr, with chronic
hepatitis B virus infection seen during a 5-yr period were analyzed. Of these,
43.8% were hepatitis B e antigen (HBeAg)-positive, 49.2% were positive for ... Cited by 193 - Related articles - All 5 versions
- ►annals.org R de Franchis, G Meucci, M Vecchi, M … - Annals of internal medicine, 1993 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To assess the long-term outcome in hepatitis B surface antigen ... Cited by 201 - Related articles - All 3 versions
- ►ntu.edu.tw [PDF] HI Yang, SN Lu, YF Liaw, SL You, CA Sun, … - The New England journal of medicine, 2002 - nejm.highwire.org Methods In 1991 and 1992, we enrolled 11,893 men without evidence of
hepatocellular carcinoma (age range, 30 to 65 years) from seven townships in
Taiwan. Serum samples obtained at the time of enrollment were tested for ... Cited by 533 - Related articles - BL Direct - All 15 versions
V Di Marco, OL Iacono, C Cammà, A Vaccaro, … - Hepatology, 1999 - interscience.wiley.com The aim of this study was to assess the long-term outcome in hepatitis B virus
(HBV)-infected patients according to HBV, hepatitis C virus (HCV), and hepatitis
D virus (HDV) replication, focusing on survival, liver failure, and ... Cited by 165 - Related articles - BL Direct - All 4 versions
YF Liaw, DY Lin, TJ Chen, CM Chu - Liver, 1989 - interscience.wiley.com ABSTRACT—To examine the early stage of the natural course of liver cirrhosis,
a prospective follow-up study was conducted in a series of 76 patients with
recent development of cirrhosis during the course of chronic type B ... Cited by 118 - Related articles - All 2 versions
- ►oxfordjournals.org [PDF] MW Yu, FC Hsu, I Sheen… - American journal of epidemiology, 1997 - Oxford Univ Press The authors conducted a study to assess the importance of underlying liver
cirrhosis in the development of hepatocellular carcinoma (HCC) and the
multifactorial etiology of liver cirrhosis in chronic carriers of hepatitis ... Cited by 165 - Related articles - BL Direct - All 4 versions
YF Liaw, DI Tai, CM Chu, TJ Chen - Hepatology, 1988 - interscience.wiley.com The incidence and contributing factors of cirrhosis developing in patients with
chronic type B hepatitis were assessed prospectively in 684
clinicopathologically verified patients, of which 509 were HBeAg positive ... Cited by 412 - Related articles - All 4 versions
